Fraunhofer Center for Molecular Biotechnology (FhCMB) is a division of Fraunhofer USA, Inc., a not-for-profit, research organization, whose mission is to develop safe and effective vaccines and therapeutics targeting infectious diseases and autoimmune disorders. Our 56,000 square foot research and development facility also houses a state of the art, cGMP pilot facility which uses our unique, plant-based technology to produce proteins. Two clinical trials are currently underway.
In The News
November 1, 2017
Daniel Eliot (right) of the Delaware Small Business Development Center works with business owners to help them get up to speed on cybersecurity. Here, he is talking with Moses Senesie, who assists SBDC with business research. Senesie is studying business …
July 26, 2017
Innovation Delaware Company to Watch: Prelude Therapeutics from a textbook or a lesson plan. “Discovery is an art,” Vaddi says. “It’s not something that’s taught.” As Vaddi’s latest business venture, Prelude Therapeutics, finds its way forward, he hopes to be …